Please select the option that best describes you:

What chemotherapy backbone will you use with pembrolizumab in the neoadjuvant setting for triple negative breast cancer?  

Will you incorporate carboplatin into the backbone as it was done in the KEYNOTE trial?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Mayo Clinic Rochester
Thanks for raising all the important questions!!&n...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Sign in or Register to read more